A review of the Vaccine Adverse Event Reporting System database

Bibliography

• BRINK EW, HINNMAN AR: The Vaccine Injury Compensation Act: the new law and you. Contemp. Peds. (1989) 6:28–42.
   Google Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination.Morb. Mortal. Wkly Rep. (1988) 37:197–200.
   PubMedGoogle Scholar
• CHEN RT, RASTOGI SC, MULLEN JR et al.: The vaccine adverse event reporting system (VAERS). Vaccine (1994) 12:542–550.
   PubMed Web of Science ®Google Scholar
• NIGHTINGALE SL: New system for reporting of vaccine adverse events. J. Am. Med. Assoc. (1990) 264:2863.
   Google Scholar
• SINGLETON JA, LLOYD JC,MOOTREY GT, SALIVE ME, CHEN RT:An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group.Vaccine (1999) 17:2908–29017.
   PubMed Web of Science ®Google Scholar
• •This article provides a good overview of the apparatus involved in the functioning of the VAERS database.
   Google Scholar
• UNITED STATES FOOD AND DRUGADMINISTRATION: Coding Symbols forThesaurus of Adverse Reaction Terms (Id edit), FDA, Rockville, MD, USA (1989).
   Google Scholar
• ZHOU W, POOL V, ISKANDER JK et al:Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991 — 2001. Morb. Mortal. Wkly Rep. (2003) 52:1–24.
   PubMedGoogle Scholar
• •This article provides a complete breakdown of the net number of doses of every type of vaccine distributed in US between 1991 — 2001.
   Google Scholar
• ROSENTHAL S, CHEN R, HADLER S: The safety of acellular pertussis vaccine versus whole-cell pertussis vaccine. A postmarketing assessment. Arch. Pediatr. Adolesc. Med. (1996) 150:457–460.
   PubMedGoogle Scholar
• ••This article provides an excellentdescription on how to analyse the VAERS database epidemiologically, by analysing the incidence rate of reported adverse events following one vaccine in comparison to another administered to a population of a similar age.
   Google Scholar
• CHEN RT, ROSENTHAL S: An errant critique that misses the mark. Arch. Pediatr. Adolesc. Med. (1996) 150:464–465.
   Google Scholar
• GEIER MR, GEIER DA: Vaccine causation of selected adverse reactions: epidemiology of the vaccine adverse event reporting system (VAERS). Thimerosal & Vecchia (2002) 1(1):32–42.
   Google Scholar
• EDWARDS KM, DECKER MD, MORTIMER EA: Pertussis vaccine. In: Vaccines (Jd edit). Orenstein WA, Plotkin SA (Eds), WB Saunders Company, New York, USA (1999):293–344.
   Google Scholar
• GEIER D, GEIER M: The true story of pertussis vaccination: a sordid legacy? J. Hist. Med. Allied Sci. (2002) 57:249–284.
   PubMedGoogle Scholar
• ••This article provides one of the mostcomplete analyses of the global history of political, economical, and social factors that have influenced the use of whole-cell and acellular pertussis vaccines.
   Google Scholar
• MILLER D, WADSWORTH, ROSS E: Severe neurological illness: further analyses of the British National Childhood Encephalopathy Study. Toka/j Exp. Clin. Med. (1988) 13(Suppl.):145–155.
   Google Scholar
• ••This study provides an excellent review ofserious neurological disorders associated with whole-cell DTP immunisation.
   Google Scholar
• MILLER D, MADGE N, DIAMOND J, WADSWORTH J, ROSS E: Pertussis immunization and serious acute neurological illnesses in children.Br. Med. J. (1993) 307:1171–1176.
   PubMedGoogle Scholar
• ••This study provides an excellent review ofpermanent brain damage associated with whole-cell DTP immunisation.
   Google Scholar
• INSTITUTE OF MEDICINE (US).Adverse Effects of Pertussis and RubellaVaccines. National Academy Press, Washington, DC, USA (1991).
   Google Scholar
• •This is an excellent review of literature on the adverse effects of pertussis and rubella vaccines.
   Google Scholar
• INSTITUTE OF MEDICINE (US): DPT vaccine and chronic nervous system dysfunction: a new analysis National Academy Press, Washington, DC, USA (1994).
   Google Scholar
• INSTITUTE OF MEDICINE (US): New Vaccine Development: Establishing Priorities. National Academy Press, Washington, DC, USA (1985).
   Google Scholar
• GEIER DA, GEIER MR: Serious neurological conditions following pertussis immunization: an analysis of endotwdn levels, the vaccine adverse events reporting system (VAERS) database and literature review. Pediatr. Rehabil (2002) 5:177–182.
   PubMedGoogle Scholar
• GEIER DA, GEIER MR: Clinical implications of endotoxin concentrations in vaccines. Ann. Pharmacother. (2002) 36:776–780.
   PubMedGoogle Scholar
• GEIER DA, GEIER MR: An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines. Brain Dev. (In Press).
   Google Scholar
• GEIER DA, GEIER MR: Rubella vaccine and arthritic adverse reactions: an analysis of the vaccine adverse events reporting system (VAERS) database from 1991 through 1998. Clin. Exp. Rheumatol (2001) 19:724–726.
   PubMedGoogle Scholar
• GEIER DA, GEIER MR: A one year follow-up of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the vaccine adverse events reporting system (VAERS) database. Clin. Exp. Rheumatol (2002) 20:767–771.
   PubMedGoogle Scholar
• •This article provides epidemiological and molecular data on the basis for the development of chronic arthritis following adult female rubella immunisation.
   Google Scholar
• INSITUTE OF MEDICINE (US): Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality National Academy Press, Washington, DC, USA (1994).
   Google Scholar
• WEIBEL RE, CASERTA V, BENOR DE, EVABS G: Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the national vaccine injury compensation program. Pediatrics (1998) 101:383–387.
   PubMedGoogle Scholar
• •Authors in this study from the US' Department of Health and Human Services present epidemiological evidenceshowing a causal relationship between measles-containing vaccines and serious neurological disorders.
   Google Scholar
• LANDRIGAN PJ, WITTE JJ: Neurologic disorders following live measles-virus vaccination. JAMA (1973) 223:1459–1462.
   PubMed Web of Science ®Google Scholar
• ALLERDIST H: Neurologicalcomplications following measles vaccination. Dev. Biol. Stand. (1979) 43:259–264.
   PubMedGoogle Scholar
• DEPARTMENT OF HHS (UK). Whooping Cough. Her Majesty's Stationary Office, London, UK (1981).
   Google Scholar
• GEIER DA, GEIER MR: Pediatric MMR vaccine safety. Int. Pediatr. (2003) 18:108–113.
   Google Scholar
• GEIER MR, GEIER DA, ZAHALSKY AC: Influenza vaccination and Guillain Barre syndrome. Gin. Immunol (2003) 107:116–121.
   Google Scholar
• •This study provides a review of the epidemiological relationship between influenza vaccines and GBS, as well as providing information about the efficacy of influenza vaccines.
   Google Scholar
• SCHONBERGER LB, BREGMAN DJ, SULLIVAN-BOLYAI JZ et al: Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am.! Epidemiol (1979) 110:105–123.
   PubMed Web of Science ®Google Scholar
• •This article presents good epidemiological evidence concerning the relationship between influenza vaccination and GBS.
   Google Scholar
• CHEN R, KENT P, RHODES P, SIMON P, SCHONBERGER L: Investigation of a possible association between influenza vaccination and Guillain-Barre syndrome in the United States, 1990-91. Post. Mark. Surveil]. (1992) 6:5–6.
   Google Scholar
• LASKY T, TERRACCIANO GJ, MAGDER L et al.: The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl. J. Med. (1998) 338:1791–1802.
   Google Scholar
• CENTERS FOR DISEASE CONTROL AND PREVENTION: Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. Morb. Mortal. Wkly Rep. (1999) 48:577–581.
   PubMedGoogle Scholar
• CENTERS OF DISEASE CONTROL AND PREVENTION: Withdrawal of rotavirus vaccine recommendation. Morb. Mortal. Wkly Rep. (1999) 48:1007.
   PubMedGoogle Scholar
• PETER G, MYERS MG; National Vaccine Advisory Committee; National Vaccine Program Office. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics (2002) 110:E67.
   Google Scholar
• GEIER DA, GEIER MR: Gastrointestinal reactions and rotavirus vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database for 1999. A model for the calculation of the incidence rates and statistical significance of adverse events following immunization. Hepatogastroenterology (2004) 51:477–481.
   Google Scholar
• BALL LK, BALL R, PRATT RD: An assessment of thimerosal use in childhood vaccines. Pediatrics (2001) 107:1147–1154.
   PubMed Web of Science ®Google Scholar
• INSTITUTE OF MEDICINE (US): Immunization Safety Review Committee Meeting: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. National Academy Press, Washington, DC, USA (2001).
   Google Scholar
• GEIER MR, GEIER DA:Neurodevelopmental disorders following thimerosal-containing childhood vaccines.Exp. Biol. Med. (2003) 228:660–664.
   PubMed Web of Science ®Google Scholar
• GEIER MR, GEIER DA: Thimerosal in childhood vaccines, neurodevelopment disorders, and heart disease in the United States. J. Am. Phys. Surg. (2003) 8:6–11.
   Google Scholar
• GEIER DA, GEIER MR: An assessment of the impact of thimerosal on neurodevelopmental disorders. Pediatr. Rehabil (2003) 6:97–102.
   PubMedGoogle Scholar
• CHEN RT, GLASSER JW, RHODES PH et al: Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 99:765–773.
   Google Scholar
• BARLOW WE, DAVIS RL, GLASSER JW et al.: The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl. J. Med. (2001) 345:656–661.
   PubMed Web of Science ®Google Scholar
• GEIER DA, GEIER MR:Lyme vaccination safety. Spirochet. Tick-Borne Dis. (2002) 9:16–22.
   Google Scholar
• GEIER MR, GEIER DA: A follow-up examination of Lyme vaccination safety. Spirochet. Tick-Borne Dis. (In Press).
   Google Scholar